Cartoux M, Msellati P, Rouamba O, Coulibaly D, Meda N, Blibolo D, Mandelbrot L, Van de Perre P, Dabis F
Centre Muraz/O.C.C.G.E., Bobo-Dioulasso, Burkina Faso.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):290-2. doi: 10.1097/00042560-199607000-00009.
Would HIV-1-positive pregnant African women use interventions of AIDS testing, medication (oral or vaginal), and vaginal disinfection to reduce the likelihood of HIV-1 transmission to their child? In this pilot study in two west African cities (Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina Faso), social workers gave a native-language questionnaire to 607 pregnant women at four Maternal and Child Health Centers. The women were asked about their perception of the HIV test; consequences of testing and counseling; choice of medical intervention to protect the future child; and feelings about being in a randomized, placebo-controlled, clinical trial. Most accepted the principle of an AIDS test, said they wanted the agreement of their regular partner before being tested, and would use interventions to reduce the risk of vertical transmission. The researchers concluded that although concepts of informed consent, randomization, and placebo are difficult to understand, the study results are promising and encourage the evaluation of clinical trials to reduce mother-to-child transmission of HIV-1 in Africa.
